NO

Novo Nordisk A/SDUS Novo Nordisk Stock Report

Last reporting period 30 Sep, 2024

Updated —

Last price

Market cap $B

65.215

Mega

Exchange

XDUS - Boerse Duesseldorf

View Full Company Analysis

Cash flow from operating activities CFO

43.9 B

Last period CFO ,DKK

236%

CFO has increased in 5 years


What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO of Novo Nordisk ?

Novo Nordisk`s CFO for the period ended 2024-09-30 is 43.9 B DKK

View Full Company Analysis